Paul M. Silva, SVP & Controller at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 13,137 shares at $247.93 ($3.2M) on 2020-02-11, disclosed to the SEC on 2020-02-12.
Seasonal sale ($3.2M) by SVP & Controller — this insider has traded VRTX in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $240.95 | 4,673 | $1.1M | 35.1% |
| 2 | $243.59 | 380 | $93K | 2.9% |
| 3 | $243.59 | 380 | $93K | 2.9% |
| 4 | $244.90 | 1,560 | $382K | 11.9% |
| 5 | $245.89 | 1,700 | $418K | 13.0% |
| 6 | $246.84 | 1,120 |
| $276K |
| 8.6% |
| 7 | $246.84 | 1,120 | $276K | 8.6% |
| 8 | $247.93 | 1,102 | $273K | 8.5% |
| 9 | $247.93 | 1,102 | $273K | 8.5% |
| Total | $244.39 avg | 13,137 | $3.2M | 100% |
| Filing → |
| VRTX | SELL | 2021-02-19 | $1.8M | — | Filing → |
| VRTX | SELL | 2021-02-16 | $586K | — | Filing → |
| VRTX | SELL | 2020-08-10 | $564K | — | Filing → |